4//SEC Filing
TherapeuticsMD, Inc. 4
Accession 0001387131-14-000811
$TXMDCIK 0000025743operating
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 7:24 PM ET
Size
9.2 KB
Accession
0001387131-14-000811
Insider Transaction Report
Form 4
Krassan Mitchell
EVP, Chief Strategy Officer
Transactions
- Sale
Common Stock
2014-03-10$7.73/sh−7,500$57,990→ 0 total - Exercise/Conversion
Common Stock
2014-03-10$0.19/sh+7,500$1,406→ 7,500 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2014-03-10−7,500→ 143,203 totalExercise: $0.19From: 2011-10-04Exp: 2020-05-01→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]The shares were sold pursuant to a 10b5-1 Sales Plan dated December 9, 2013.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.64 to $7.81, inclusive. The reporting person undertakes to provide TherapeuticsMD, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0000025743
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 7:24 PM ET
- Size
- 9.2 KB